Boris V Moskvichev

Title: **Boris V Moskvichev: Innovator in Fibrinolysin Derivatives**

Introduction

Boris V Moskvichev, an esteemed inventor based in Saint-Petersburg, Russia, has made significant contributions to the field of biomedical research. With a focus on polysaccharide derivatives, Moskvichev holds a patent that addresses important advancements in fibrinolysis. His innovative work plays a crucial role in enhancing medical therapies related to blood clotting.

Latest Patents

Moskvichev's sole patent is titled "Dextran derivative of fibrinolysin." This patent details a method for preparing a polysaccharide derivative of fibrinolysin by reacting fibrinolysin with dextran dialdehyde. The process occurs within a specific molecular mass range of 20,000 to 110,000, at a pH of 8.0 to 9.5, and at temperatures between 5°C and 30°C. The resultant fibrinolysin derivative is then reduced with sodium borohydride and isolated, creating a compound that could potentially improve therapeutic outcomes in the medical field.

Career Highlights

Boris V Moskvichev works at the All-Union Cardiological Scientific Center, an institution renowned for its research in cardiovascular health. His career is marked by his determination to innovate and improve existing medical therapies through scientific research and patentable inventions.

Collaborations

Throughout his career, Moskvichev has collaborated with notable colleagues, including Evgeny I Chazov and Vladimir N Smirnov. Their teamwork reflects a shared commitment to advancing cardiovascular medicine and the development of effective pharmacological solutions.

Conclusion

Boris V Moskvichev stands out as an influential inventor within the realm of polysaccharide derivatives. His patented method not only showcases his innovative spirit but also contributes significantly to the advancement of medical therapies. As his career continues to evolve, Moskvichev remains a pivotal figure in the intersection of biochemistry and medical science.